Serum interleukin-23 protects, whereas methotrexate...

  • Main
  • 2018
  • Serum interleukin-23 protects, whereas methotrexate...

Serum interleukin-23 protects, whereas methotrexate treatment stimulates selected components of the metabolic syndrome in patients with SAPHO syndrome

Przepiera-Będzak, Hanna, Fischer, Katarzyna, Brzosko, Marek
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Year:
2018
Journal:
Archives of Medical Science
DOI:
10.5114/aoms.2018.76953
File:
PDF, 79 KB
2018
Conversion to is in progress
Conversion to is failed